Effect of vasodilator therapy on mortality in chronic congestive heart failure

J. N. Cohn

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

The reduction of mortality in patients with chronic congestive heart failure treated with the vasodilator regimen hydralazine and isosorbide dinitrate compared to those treated with placebo or prazosin in the Veterans Administration Cooperative Study (V-HeFT) was examined in order to explore the possible mechanism of the favourable effect. Similar efficacy in coronary and non-coronary disease patients tends to discount a prominent effect on myocardial perfusion. The most likely explanation for the prolonged survival on the effective vasodilator regimen is that these drugs tend to increase left ventricular ejection fraction, probably by a sustained effect on preload and impedance.

Original languageEnglish (US)
Pages (from-to)171-173
Number of pages3
JournalEuropean heart journal
Volume9
Issue numberSUPPL. A
DOIs
StatePublished - 1988

Fingerprint

Dive into the research topics of 'Effect of vasodilator therapy on mortality in chronic congestive heart failure'. Together they form a unique fingerprint.

Cite this